TEAR - TearLab Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.171
-0.013 (-6.86%)
As of 10:57AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.184
Open0.187
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.170 - 0.190
52 Week Range0.120 - 2.060
Volume21,570
Avg. Volume39,062
Market Cap1.846M
Beta0.23
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press5 days ago

    TearLab: 2Q Earnings Snapshot

    On a per-share basis, the San Diego-based company said it had a loss of 6 cents. The ophthalmic device company posted revenue of $6.4 million in the period. In the final minutes of trading on Thursday, ...

  • Associated Press3 months ago

    TearLab: 1Q Earnings Snapshot

    On a per-share basis, the San Diego-based company said it had a loss of 9 cents. The ophthalmic device company posted revenue of $6.4 million in the period. The company's shares closed at 24 cents. A year ...

  • Associated Press5 months ago

    TearLab reports 4Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 63 cents. Losses, adjusted for asset impairment costs, came to 55 cents per share. The ophthalmic device company posted revenue of ...

  • TearLab Corp. :TEAR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
    Capital Cube8 months ago

    TearLab Corp. :TEAR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis TearLab Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of TearLab Corp. – STAAR Surgical Company, Atrion Corporation and Vuzix Corporation (STAA-US, ATRI-US and VUZI-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 6.52 ... Read more (Read more...)

  • Thomson Reuters StreetEvents9 months ago

    Edited Transcript of TEAR earnings conference call or presentation 13-Nov-17 9:30pm GMT

    Q3 2017 TearLab Corp Earnings Call

  • Associated Press9 months ago

    TearLab reports 3Q loss

    The San Diego-based company said it had a loss of 67 cents per share. The ophthalmic device company posted revenue of $6.5 million in the period. In the final minutes of trading on Monday, the company's ...

  • Who Are TearLab Corporation’s (TEAR) Major Shareholders?
    Simply Wall St.9 months ago

    Who Are TearLab Corporation’s (TEAR) Major Shareholders?

    In this analysis, my focus will be on developing a perspective on TearLab Corporation’s (NASDAQ:TEAR) latest ownership structure, a less discussed, but important factor. The impact of a company’s ownershipRead More...

  • Is TearLab Corporation (TEAR) Cheap And High Growth?
    Simply Wall St.10 months ago

    Is TearLab Corporation (TEAR) Cheap And High Growth?

    TearLab Corporation (NASDAQ:TEAR), a USD$8.15M small-cap, is a healthcare company operating in an industry, which faces more complex and interdependent challenges, requiring multi-pronged, collaborative, and technology-enabled business models. Healthcare analystsRead More...

  • Zacks.com featured highlights include MINDBODY, TearLab, Sunesis Pharmaceuticals, Children's Place, Franklin Electric
    Zacks10 months ago

    Zacks.com featured highlights include MINDBODY, TearLab, Sunesis Pharmaceuticals, Children's Place, Franklin Electric

    Zacks.com featured highlights include MINDBODY, TearLab, Sunesis Pharmaceuticals, Children's Place, Franklin Electric

  • Step Beyond Bargain Hunting: 5 Stocks With Rising P/E
    Zacks10 months ago

    Step Beyond Bargain Hunting: 5 Stocks With Rising P/E

    Bet on these top-ranked stocks with rising P/E to realize outsized gains.

  • TearLab Corporation (TEAR): How Does It Impact Your Portfolio?
    Simply Wall St.10 months ago

    TearLab Corporation (TEAR): How Does It Impact Your Portfolio?

    If you are looking to invest in TearLab Corporation’s (NASDAQ:TEAR), or currently own the stock, then you need to understand its beta in order to understand how it can affectRead More...

  • Stocks Near 52-Week Lows: 4 Attractive Picks
    Zacks11 months ago

    Stocks Near 52-Week Lows: 4 Attractive Picks

    Fundamentally strong stocks trading around their 52-week lows make for a great bargain, despite how weak the broader market considers them right now.

  • Capital Cube11 months ago

    ETFs with exposure to TearLab Corp. : September 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TearLab Corp. Here are 5 ETFs with the largest exposure to TEAR-US. Comparing the performance and risk of TearLab Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEventslast year

    Edited Transcript of TEAR earnings conference call or presentation 14-Aug-17 8:30pm GMT

    Q2 2017 TearLab Corp Earnings Call

  • Associated Presslast year

    TearLab reports 2Q loss

    The San Diego-based company said it had a loss of 68 cents per share. The ophthalmic device company posted revenue of $7 million in the period, which topped Street forecasts. Three analysts surveyed by ...